TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
+21.98%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$679M
AUM Growth
+$8.14M
(+1.2%)
Cap. Flow
-$20M
Cap. Flow
% of AUM
-2.94%
Top 10 Holdings %
Top 10 Hldgs %
38.68%
Holding
124
New
21
Increased
25
Reduced
15
Closed
25
Top Buys
| 1 |
InflaRx
IFRX
|
$12.9M |
| 2 |
Verastem
VSTM
|
$8.48M |
| 3 |
Atea Pharmaceuticals
AVIR
|
$7.57M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
$5.98M |
| 5 |
ADMA Biologics
ADMA
|
$4.65M |
Top Sells
| 1 |
Novo Nordisk
NVO
|
$21.5M |
| 2 |
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
|
$9.81M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$9.01M |
| 4 |
BLUE
bluebird bio
BLUE
|
$8.23M |
| 5 |
Moderna
MRNA
|
$7.29M |
Sector Composition
| 1 | Healthcare | 92.72% |
| 2 | Financials | 6.8% |
| 3 | Real Estate | 0.3% |
| 4 | Consumer Discretionary | 0.15% |
| 5 | Utilities | 0.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Aurinia Pharmaceuticals
AUPH
$1.58B
| $1.45M | 0.21% |
+150,000
| New | +$1.45M |
|
77
Bank of Hawaii
BOH
$2.69B
| $1.24M | 0.18% |
+30,000
| New | +$1.24M |
|
78
ServisFirst Bancshares
SFBS
$4.77B
| $1.23M | 0.18% |
30,000
| – | – |
|
79
Invivyd
IVVD
$218M
| $1.21M | 0.18% |
1,151,843
+751,843
| +188% | +$789K |
|
80
CRISPR Therapeutics
CRSP
$4.82B
| $1.12M | 0.17% |
+20,000
| New | +$1.12M |
|
81
Athira Pharma
ATHA
$15.5M
| $1.04M | 0.15% |
352,715
| – | – |
|
82
Inspirato
ISPO
$36.4M
| $1.01M | 0.15% |
51,750
+32,750
| +172% | +$642K |
|
83
Ascendis Pharma
ASND
$12.1B
| $893K | 0.13% |
+10,000
| New | +$893K |
|
84
NextCure
NXTC
$13.3M
| $720K | 0.11% |
33,333
| – | – |
|
85
908 Devices
MASS
$214M
| $686K | 0.1% |
+100,000
| New | +$686K |
|
86
Tango Therapeutics
TNGX
$745M
| $664K | 0.1% |
200,000
| – | – |
|
87
PDS Biotechnology
PDSB
$60.6M
| $503K | 0.07% |
+100,000
| New | +$503K |
|
88
Stellar Bancorp
STEL
$1.58B
| $458K | 0.07% |
20,000
+10,000
| +100% | +$229K |
|
89
Cartesian Therapeutics
RNAC
$267M
| $448K | 0.07% |
+13,333
| New | +$448K |
|
90
Neuronetics
STIM
$216M
| $430K | 0.06% |
+200,000
| New | +$430K |
|
91
GeneDx Holdings
WGS
$3.65B
| $379K | 0.06% |
+63,636
| New | +$379K |
|
|
ATYR
92
aTyr Pharma
ATYR
$560M
| $324K | 0.05% |
150,000
+26,570
| +22% | +$57.4K |
|
93
Equillium
EQ
$66.8M
| $300K | 0.04% |
400,000
+311,432
| +352% | +$234K |
|
94
Passage Bio
PASG
$22.6M
| $282K | 0.04% |
15,000
| – | – |
|
|
FRLN
95
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
| $258K | 0.04% |
+100,000
| New | +$258K |
|
|
MOLN
96
Molecular Partners
MOLN
$139M
| $247K | 0.04% |
39,753
+1,500
| +4% | +$9.33K |
|
97
Talphera
TLPH
$11.2M
| $216K | 0.03% |
195,000
| – | – |
|
98
Smart Powerr
CREG
$3.92M
| $203K | 0.03% |
+12,506
| New | +$203K |
|
99
Nektar Therapeutics
NKTR
$543M
| $80.3K | 0.01% |
9,307
| – | – |
|
|
ALLK
100
DELISTED
Allakos
ALLK
| – | – |
-447,967
| Closed | -$1.99M |
|